A Multicenter Real-World Data of Cladribine Tablets in Patients with Multiple Sclerosis in Turkey

被引：0
|
作者：
Koseoglu, Mesrure [1 ]
Omerhoca, Sami [2 ]
Balci, Fatma Belgin [3 ]
Unal, Aysun [4 ]
Ozdemir, Zeynep [1 ]
Yuksel, Burcu [1 ]
Celik, Rabia Gokcen Gozubatik [1 ]
Toprak, Ufuk Emre [5 ]
Gursoy, Esra Azize [6 ]
Icen, Nilufer Kale [2 ]
Altunrende, Burcu [7 ]
机构：
[1] Univ Hlth Sci, Bakirkoy Res & Training Hosp Neurol & Psychiat Di, Dept Neurol, Istanbul, Turkiye
[2] SBU Bagcilar Training & Res Hosp, Dept Neurol, Istanbul, Turkiye
[3] Haseki Educ & Res Hosp, Dept Neurol, Istanbul, Turkiye
[4] Tekirdag Namik Kemal Univ, Dept Neurol, Fac Med, Tekirdag, Turkiye
[5] Istanbul Educ & Res Hosp, Dept Neurol, Istanbul, Turkiye
[6] Basaksehir Cam & Sakura City Hosp, Dept Neurol, Istanbul, Turkiye
[7] Taksim Educ & Res Hosp, Dept Neurol, Istanbul, Turkiye
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1598/1823
引用
收藏
页码：1017 / 1017
页数：1
相关论文
共 50 条
  • [21] Real-world experience with cladribine tablets in the msbase registry
    Butzkueven, H.
    Spelman, T.
    Hodgkinson, S.
    Kalincik, T.
    Buzzard, K.
    Skibina, O.
    Eichau Madueno, S.
    Izquierdo, G.
    Van der Walt, A.
    Grand-Maison, F.
    Butler, E.
    Prevost, J.
    Mccombe, P.
    Oh, J.
    Macdonell, R.
    Lechner-Scott, J.
    Van Pesch, V.
    Duquette, P.
    Prat, A.
    Girard, M.
    Kermode, A.
    Fabris, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 549 - 549
  • [22] Response of Hispanic Puerto Rican Multiple Sclerosis Patients Switched from High Efficacy Therapies to cladribine Tablets in a Real-World Setting
    Chinea, Angel
    Vega-Corteguera, Ramon
    Martinez-Maldonado, Viviana
    Vicente, Ivonne
    Navedo-Santos, Jessenia
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1112 - 1112
  • [23] Long-term Real-world Safety and Efficacy of Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis: The UAE Experience
    Yamout, Bassem I.
    Shatila, Ahmad
    Inshasi, Jihad
    Hassan, Ali Mohammed Ali
    Szolics, Mikolas
    Hassan, Ahmed
    Farw, Ahmed
    Ismail, Ghida
    Zeineddine, Maya
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 379 - 379
  • [24] Cladribine tablets in people with relapsing multiple sclerosis: A real-world multicentric study from southeast European MS centers
    Adamec, Ivan
    Jakob, Gregor Brecl
    Rajda, Cecilia
    Drulovic, Jelena
    Radulovic, Ljiljana
    Kes, Vanja Basic
    Lazibat, Ines
    Rimac, Julija
    Cindric, Igor
    Grzincic, Tihana
    Abicic, Ana
    Barun, Barbara
    Gabelic, Tereza
    Gomezelj, Sarah
    Mesaros, Sarlota
    Pekmezovic, Tatjana
    Klivenyi, Peter
    Skoric, Magdalena Krbot
    Habek, Mario
    JOURNAL OF NEUROIMMUNOLOGY, 2023, 382
  • [25] Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study)
    Arena, Sebastiano
    Chisari, Clara Grazia
    Toscano, Simona
    Bucello, Sebastiano
    Grimaldi, Luigi Maria
    Ragonese, Paolo
    Realmuto, Sabrina
    Cottone, Salvatore
    Maimone, Davide
    Finocchiaro, Chiara
    Reitano, Paola
    Patti, Francesco
    CURRENT NEUROPHARMACOLOGY, 2024, 22 (07) : 1271 - 1283
  • [26] REAL-WORLD PERSISTENCE ON CLADRIBINE TABLETS OF PATIENTS WITH RMS OVER 4 YEARS BASED ON CLAIMS DATA
    Giesl, N.
    Stahn, D.
    Osowski, U.
    VALUE IN HEALTH, 2023, 26 (12) : S505 - S506
  • [27] Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina
    Rojas, Juan Ignacio
    Alonso, Ricardo
    Luetic, Geraldine
    Patrucco, Liliana
    Casas, Magdalena
    Silva, Berenice
    Miguez, Jimena
    Deri, Norma
    Vrech, Carlos
    Liwacki, Susana
    Piedrabuena, Raul
    Silva, Emanuel
    Tkachuk, Veronica
    Burgos, Marcos
    Tavolini, Dario
    Zanga, Gisela
    Pinheiro, Amelia Alvez
    Hryb, Javier
    Leguizamon, Felisa
    Knorre, Eduardo
    Lopez, Pablo A.
    Martinez, Alejandra
    Carra, Adriana
    Serena, Marina Alonso
    Cristiano, Edgardo
    Correale, Jorge
    Garcea, Orlando
    Liguori, Nora Fernandez
    Contentti, Edgar Carnero
    CLINICAL NEUROPHARMACOLOGY, 2024, 47 (04) : 120 - 127
  • [28] A real-world single-centre analysis of alemtuzumab and cladribine for multiple sclerosis
    Bose, Gauruv
    Rush, Carolina
    Atkins, Harold L.
    Freedman, Mark S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
  • [29] Predictors of cladribine effectiveness in multiple sclerosis: a real-world, multicenter, two-year follow-up study
    Petracca, M.
    Ruggieri, S.
    Barbuti, E.
    Ianniello, A.
    Fantozzi, R.
    Di Lemme, S.
    Maniscalco, G.
    Landi, D.
    Marfia, G.
    Di Gregorio, M.
    Iodice, R.
    Sinisi, L.
    Missione, R.
    Coppola, C.
    Bonavita, S.
    Borriello, G.
    Lus, G.
    Pozzilli, C.
    Signoriello, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 787 - 787
  • [30] Real-World Experience in an Irish Centre using Cladribine in Patients with Relapsing-Remitting Multiple Sclerosis
    O'Donnell, Martin
    Pavalaghanthan, Hariesh
    Jose, Shinto
    Mitten, Ethna
    Ryan, Aisling
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1000 - 1001
12345